BLD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TopBuild is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is being held near the acquisition price, but the technical setup is mixed, analysts are broadly turning cautious, and the latest quarter showed revenue growth but weaker profitability. The deal with QXO provides a valuation anchor, yet the current setup does not offer a clean, high-conviction long-term entry at this moment.
BLD closed at 426.99, slightly below the previous close and below the pivot at 443.71, with support at 428.24 and 418.68. Short-term trend is mixed: SMA_5 is above SMA_20 and SMA_200, which is bullish, but MACD histogram is -2.093 and expanding negatively, showing weakening momentum. RSI_6 at 43.4 is neutral and does not signal oversold strength. Overall, the chart suggests a holding pattern with mild downside pressure rather than a compelling immediate breakout setup.
["QXO acquisition at $505 per share creates a clear deal-value anchor for the stock.", "Q1 revenue rose 17.24% year over year to $1.446 billion, showing strong top-line growth.", "Q1 non-GAAP EPS of $3.75 beat expectations and confirms solid operating execution.", "Analyst targets remain clustered near or above the current price, with some firms still seeing upside to the deal price."]
["Analysts have recently downgraded the stock to Hold/Neutral, reflecting weakening conviction.", "Hedge funds are selling aggressively, with selling up 2972.24% over the last quarter.", "Q1 net income fell 15.05% year over year and EPS declined 11.82%, showing margin pressure.", "Gross margin dropped 6.45% year over year, signaling weaker profitability despite revenue growth.", "Put-heavy options positioning suggests cautious sentiment and downside hedging.", "Residential pricing and unit trends were described as weak in analyst commentary."]
In 2026/Q1, TopBuild delivered revenue of $1.446 billion, up 17.24% year over year, which is a strong growth signal for the latest quarter season. However, profitability softened: net income declined 15.05% year over year to $104.8 million, EPS fell 11.82% to $3.73, and gross margin slipped to 27.68% from the prior year. So the quarter showed solid sales growth but weaker bottom-line quality.
The recent analyst trend has turned more cautious. Truist raised its target to $440 but kept Hold, Loop Capital downgraded to Hold, and DA Davidson cut to Neutral with a lower target after the Q1 report and acquisition news. JPMorgan also moved to Neutral, while Evercore had previously lifted its target to match the deal value. Overall, Wall Street is split between deal-driven upside and soft operating fundamentals, but the dominant tone is now Hold/Neutral rather than Buy.
